Il y a eu 50 transactions d'initiés récentes enregistrées pour United Therapeutics Corporation (UTHR), dont 0 achats et 47 ventes. Le total des achats d'initiés s'élève à RSU Award et le total des ventes d'initiés à $33.08M.
Les initiés notables ayant une activité récente comprennent Rothblatt Martine A, Edgemond James, Mahon Paul A. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — UTHR
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-04-06 |
Rothblatt Martine A |
Chairperson & CEO |
Exercice d'Options (Vente) |
9,500 |
$146.03 |
$1.39M |
2,500 |
| 2026-04-06 |
Edgemond James |
CFO and Treasurer |
Vente Informative |
200 |
$566.01 |
$113.2K |
18,876 |
| 2026-04-02 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
8,300 |
$146.03 |
$1.21M |
16,900 |
| 2026-04-02 |
Rothblatt Martine A |
Chairperson & CEO |
Exercice d'Options (Vente) |
9,500 |
$146.03 |
$1.39M |
12,000 |
| 2026-04-02 |
Edgemond James |
CFO and Treasurer |
Vente Informative |
120 |
$571.65 |
$68.6K |
18,876 |
| 2026-04-01 |
Rothblatt Martine A |
Chairperson & CEO |
Don (Donné) |
500,000 |
$117.76 |
$58.88M |
- |
| 2026-03-31 |
Rothblatt Martine A |
Chairperson & CEO |
Exercice d'Options (Vente) |
9,500 |
$146.03 |
$1.39M |
31,000 |
| 2026-03-30 |
Rothblatt Martine A |
Chairperson & CEO |
Vente Informative |
80 |
$581.74 |
$46.54K |
49,933 |
| 2025-06-26 |
Mahon Paul A |
EVP & General Counsel |
Vente Informative |
100 |
$288.80 |
$28.88K |
36,781 |
| 2025-06-24 |
Giltner Richard |
Director |
Exercice d'Options (Vente) |
5,000 |
$175.43 |
$877.15K |
- |
| 2025-06-24 |
Mesa Nilda |
Director |
Vente Informative |
645 |
$289.99 |
$187.05K |
4,883 |
| 2025-06-12 |
Mahon Paul A |
EVP & General Counsel |
Vente Informative |
200 |
$282.27 |
$56.45K |
36,781 |
| 2025-06-09 |
Edgemond James |
CFO and Treasurer |
Vente Informative |
300 |
$326.81 |
$98.04K |
8,118 |
| 2025-06-02 |
Edgemond James |
CFO and Treasurer |
Vente Informative |
2,653 |
$326.31 |
$865.69K |
8,118 |
| 2025-05-29 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
4,000 |
$117.76 |
$471.04K |
- |
| 2025-05-15 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
11,000 |
$117.76 |
$1.3M |
4,000 |
| 2025-05-09 |
Thompson Tommy G |
Director |
Exercice d'Options (Vente) |
2,500 |
$175.43 |
$438.58K |
- |
| 2025-05-01 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
11,000 |
$117.76 |
$1.3M |
15,000 |
| 2025-04-21 |
Dwek Raymond |
Director |
Exercice d'Options (Vente) |
3,000 |
$175.43 |
$526.29K |
- |
| 2025-04-17 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
11,000 |
$117.76 |
$1.3M |
26,000 |
| 2025-04-14 |
Dwek Raymond |
Director |
Vente Informative |
3,000 |
$285.16 |
$855.48K |
1,750 |
| 2025-04-07 |
Dwek Raymond |
Director |
Vente Informative |
4,000 |
$284.55 |
$1.14M |
1,750 |
| 2025-04-03 |
Mahon Paul A |
EVP & General Counsel |
Vente Informative |
1,501 |
$308.08 |
$462.43K |
36,781 |
| 2025-03-24 |
Thompson Tommy G |
Director |
Exercice d'Options (Vente) |
2,500 |
$175.43 |
$438.58K |
2,500 |
| 2025-03-19 |
Patusky Christopher |
Director |
Exercice d'Options (Vente) |
5,000 |
$175.43 |
$877.15K |
- |
| 2025-03-10 |
Benkowitz Michael |
President and COO |
Exercice d'Options (Vente) |
2,000 |
$111.00 |
$222K |
- |
| 2025-03-07 |
Rothblatt Martine A |
Chairperson & CEO |
Don (Donné) |
229,947 |
- |
- |
15,962 |
| 2025-03-06 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
6,550 |
$163.30 |
$1.07M |
- |
| 2025-03-03 |
Benkowitz Michael |
President and COO |
Vente Informative |
137 |
$318.82 |
$43.68K |
- |
| 2025-02-28 |
Kurzweil Ray |
Director |
Exercice d'Options (Vente) |
15,000 |
$175.43 |
$2.63M |
- |
| 2025-02-28 |
Thompson Tommy G |
Director |
Exercice d'Options (Vente) |
2,500 |
$175.43 |
$438.58K |
5,000 |
| 2025-02-24 |
Benkowitz Michael |
President and COO |
Vente Informative |
400 |
$364.27 |
$145.71K |
- |
| 2025-02-20 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
7,700 |
$163.30 |
$1.26M |
6,550 |
| 2025-02-18 |
Benkowitz Michael |
President and COO |
Vente Informative |
400 |
$373.67 |
$149.47K |
- |
| 2025-02-10 |
Benkowitz Michael |
President and COO |
Vente Informative |
45 |
$352.43 |
$15.86K |
- |
| 2025-02-06 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
7,700 |
$163.30 |
$1.26M |
14,250 |
| 2025-02-03 |
Benkowitz Michael |
President and COO |
Vente Informative |
500 |
$357.01 |
$178.51K |
- |
| 2025-01-27 |
Benkowitz Michael |
President and COO |
Vente Informative |
100 |
$375.22 |
$37.52K |
- |
| 2025-01-21 |
Benkowitz Michael |
President and COO |
Vente Informative |
245 |
$368.08 |
$90.18K |
- |
| 2025-01-16 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
7,700 |
$163.30 |
$1.26M |
21,950 |
| 2025-01-13 |
Benkowitz Michael |
President and COO |
Vente Informative |
100 |
$367.99 |
$36.8K |
- |
| 2025-01-10 |
Patusky Christopher |
Director |
Vente Informative |
109 |
$363.86 |
$39.66K |
900 |
| 2025-01-06 |
Benkowitz Michael |
President and COO |
Vente Informative |
300 |
$358.32 |
$107.5K |
- |
| 2025-01-02 |
Mahon Paul A |
EVP & General Counsel |
Exercice d'Options (Vente) |
7,700 |
$163.30 |
$1.26M |
29,650 |
| 2024-12-30 |
Benkowitz Michael |
President and COO |
Vente Informative |
400 |
$358.18 |
$143.27K |
- |
| 2024-12-30 |
Mesa Nilda |
Director |
Vente Informative |
255 |
$355.77 |
$90.72K |
5,528 |
| 2024-12-23 |
Benkowitz Michael |
President and COO |
Vente Informative |
1,100 |
$363.87 |
$400.26K |
- |
| 2024-12-19 |
Sullivan Louis W |
Director |
Don (Donné) |
1,851 |
- |
- |
3,200 |
| 2024-12-19 |
Mahon Paul A |
EVP & General Counsel |
Restitution d'Actions |
7,700 |
$360.16 |
$2.77M |
36,710 |
| 2024-12-18 |
Sullivan Louis W |
Director |
Exercice d'Options (Vente) |
15,000 |
$175.43 |
$2.63M |
- |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
